Literature DB >> 11458496

Limited telomere shortening in hematopoietic stem cells after transplantation.

T H Brümmendorf1, N Rufer, G M Baerlocher, E Roosnek, P M Lansdorp.   

Abstract

The number of cell divisions in hematopoietic stem cells (HSCs) following transplantation of bone marrow or mobilized peripheral blood into myelo-ablated recipients is unknown. This number is expected to depend primarily on the number of transplanted stem cells, assuming that stem cells do not differ in engraftment potential and other functional properties. In a previous study, we found that the telomere length in circulating granulocytes in normal individuals shows a biphasic decline with age, most likely reflecting age-related changes in the turnover of HSCs. In order to study HSCs' proliferation kinetics following stem cells transplantation, we analyzed the telomere length in donor-derived nucleated blood cells in four HLA-matched bone marrow transplant recipients relative to comparable cells from the sibling donors. In each case, the telomeres in granulocytes were shorter in the recipient than in the donor. This difference was established in the first year post transplantation and did not change after that. The telomere length in naïve and memory T cells showed marked differences after transplantation, complicating the interpretation of telomere length data using unseparated nucleated blood cells. Interestingly, the telomere length in naïve T cells that were first observed six months post transplantation was very similar in donor and recipient pairs. Our observations are compatible with a limited number of additional cell divisions in stem cell populations after bone marrow transplantations and support the idea that different populations of stem cells contribute to short-term myeloid and long-term lympho myeloid hematopoiesis.

Entities:  

Mesh:

Year:  2001        PMID: 11458496     DOI: 10.1111/j.1749-6632.2001.tb03568.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  10 in total

1.  Isolation and therapeutic potential of human haemopoietic stem cells.

Authors:  Andrew D Clark; Heather G Jørgensen; Joanne Mountford; Tessa L Holyoake
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

Review 2.  Bone marrow failure and the telomeropathies.

Authors:  Danielle M Townsley; Bogdan Dumitriu; Neal S Young
Journal:  Blood       Date:  2014-09-18       Impact factor: 22.113

Review 3.  Telomere biology in hematopoiesis and stem cell transplantation.

Authors:  Shahinaz M Gadalla; Sharon A Savage
Journal:  Blood Rev       Date:  2011-07-20       Impact factor: 8.250

4.  Telomere content measurement in human hematopoietic cells: Comparative analysis of qPCR and Flow-FISH techniques.

Authors:  Taylor Wand; Mike Fang; Christina Chen; Nathan Hardy; J Philip McCoy; Bogdan Dumitriu; Neal S Young; Angélique Biancotto
Journal:  Cytometry A       Date:  2016-09-22       Impact factor: 4.355

Review 5.  The role of telomere biology in bone marrow failure and other disorders.

Authors:  Sharon A Savage; Blanche P Alter
Journal:  Mech Ageing Dev       Date:  2007-11-19       Impact factor: 5.432

6.  Accelerated telomere shortening precedes development of therapy-related myelodysplasia or acute myelogenous leukemia after autologous transplantation for lymphoma.

Authors:  Sujata Chakraborty; Can-Lan Sun; Liton Francisco; Melanie Sabado; Liang Li; Karen L Chang; Stephen Forman; Smita Bhatia; Ravi Bhatia
Journal:  J Clin Oncol       Date:  2009-01-05       Impact factor: 44.544

7.  Characterization of primitive hematopoietic cells from patients with dyskeratosis congenita.

Authors:  Frederick D Goldman; Geraldine Aubert; Al J Klingelhutz; Mark Hills; Sarah R Cooper; Wendy S Hamilton; Annette J Schlueter; Karen Lambie; Connie J Eaves; Peter M Lansdorp
Journal:  Blood       Date:  2008-02-29       Impact factor: 22.113

Review 8.  Evaluation and Management of Hematopoietic Failure in Dyskeratosis Congenita.

Authors:  Suneet Agarwal
Journal:  Hematol Oncol Clin North Am       Date:  2018-05-28       Impact factor: 3.722

Review 9.  Therapeutic myocardial angiogenesis: past, present and future.

Authors:  Mickey Scheinowitz
Journal:  Mol Cell Biochem       Date:  2004-09       Impact factor: 3.396

10.  Telomere length is severely and similarly reduced in JAK2V617F-positive and -negative myeloproliferative neoplasms.

Authors:  L Bernard; C Belisle; L Mollica; S Provost; D-C Roy; D G Gilliland; R L Levine; L Busque
Journal:  Leukemia       Date:  2008-11-13       Impact factor: 11.528

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.